3.22.1 html 178 311 1 false 58 0 false 6 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - BALANCE SHEETS Sheet http://www.oricpharma.com/20211231/taxonomy/role/StatementBalanceSheets1 BALANCE SHEETS Statements 2 false false R3.htm 100030 - Statement - BALANCE SHEETS (Parenthetical) Sheet http://www.oricpharma.com/20211231/taxonomy/role/StatementBalanceSheetsParenthetical BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 100040 - Statement - STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_StatementSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Statements 4 false false R5.htm 100050 - Statement - STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_StatementSTATEMENTSOFCONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) Statements 5 false false R6.htm 100060 - Statement - STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_StatementSTATEMENTSOFCONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICITParenthetical STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) Statements 6 false false R7.htm 100070 - Statement - STATEMENTS OF CASH FLOWS Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_StatementSTATEMENTSOFCASHFLOWS STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 100080 - Disclosure - Description of the Business Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureDescriptionOfBusiness Description of the Business Notes 8 false false R9.htm 100090 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies Basis of Presentation and Summary of Significant Accounting Policies Notes 9 false false R10.htm 100100 - Disclosure - License Agreements Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureLicenseAgreements License Agreements Notes 10 false false R11.htm 100110 - Disclosure - Property and Equipment, Net Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNet Property and Equipment, Net Notes 11 false false R12.htm 100120 - Disclosure - Accrued Liabilities Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureAccruedLiabilities Accrued Liabilities Notes 12 false false R13.htm 100130 - Disclosure - Investments, Available-for-Sale Sheet http://www.oricpharma.com/20211231/taxonomy/role/DisclosureInvestmentsAvailableforsale Investments, Available-for-Sale Notes 13 false false R14.htm 100140 - Disclosure - Fair Value Measurements Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurements Fair Value Measurements Notes 14 false false R15.htm 100150 - Disclosure - Convertible Preferred Stock Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStock Convertible Preferred Stock Notes 15 false false R16.htm 100160 - Disclosure - Equity Incentive Plans and Stock-Based Compensation Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureEquityIncentivePlansAndStockBasedCompensation Equity Incentive Plans and Stock-Based Compensation Notes 16 false false R17.htm 100170 - Disclosure - Income Tax Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureIncomeTax Income Tax Notes 17 false false R18.htm 100180 - Disclosure - Commitments and Contingencies Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 18 false false R19.htm 100190 - Disclosure - Employee Benefit Plan Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureEmployeeBenefitPlan Employee Benefit Plan Notes 19 false false R20.htm 100200 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies Basis of Presentation and Summary of Significant Accounting Policies (Policies) Policies http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies 20 false false R21.htm 100210 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables Basis of Presentation and Summary of Significant Accounting Policies (Tables) Tables http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies 21 false false R22.htm 100220 - Disclosure - Property and Equipment, Net (Tables) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetTables Property and Equipment, Net (Tables) Tables http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNet 22 false false R23.htm 100230 - Disclosure - Accrued Liabilities (Tables) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureAccruedLiabilitiesTables Accrued Liabilities (Tables) Tables http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureAccruedLiabilities 23 false false R24.htm 100240 - Disclosure - Investments, Available-for-Sale (Tables) Sheet http://www.oricpharma.com/20211231/taxonomy/role/DisclosureInvestmentsAvailableforsaleTables Investments, Available-for-Sale (Tables) Tables http://www.oricpharma.com/20211231/taxonomy/role/DisclosureInvestmentsAvailableforsale 24 false false R25.htm 100250 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurements 25 false false R26.htm 100260 - Disclosure - Convertible Preferred Stock (Tables) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStockTables Convertible Preferred Stock (Tables) Tables http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStock 26 false false R27.htm 100270 - Disclosure - Equity Incentive Plans and Stock-Based Compensation (Tables) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureEquityIncentivePlansAndStockBasedCompensationTables Equity Incentive Plans and Stock-Based Compensation (Tables) Tables http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureEquityIncentivePlansAndStockBasedCompensation 27 false false R28.htm 100280 - Disclosure - Income Tax (Tables) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxTables Income Tax (Tables) Tables http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureIncomeTax 28 false false R29.htm 100290 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies 29 false false R30.htm 100300 - Disclosure - Description of the Business - Additional Information (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureDescriptionOfBusinessAdditionalInformationDetails Description of the Business - Additional Information (Details) Details 30 false false R31.htm 100310 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details) Details 31 false false R32.htm 100320 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Summary of Cash, Cash Equivalents and Restricted Cash (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsAndRestrictedCashDetails Basis of Presentation and Summary of Significant Accounting Policies - Summary of Cash, Cash Equivalents and Restricted Cash (Details) Details 32 false false R33.htm 100330 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Summary of Computation of Basic and Diluted Net Loss Per Share (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfComputationOfBasicAndDilutedNetLossPerShareDetails Basis of Presentation and Summary of Significant Accounting Policies - Summary of Computation of Basic and Diluted Net Loss Per Share (Details) Details 33 false false R34.htm 100340 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Summary of Outstanding Shares of Potentially Dilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSummaryOfOutstandingSharesOfPotentiallyDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails Basis of Presentation and Summary of Significant Accounting Policies - Summary of Outstanding Shares of Potentially Dilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Details) Details 34 false false R35.htm 100350 - Disclosure - License Agreements - Additional Information (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureLicenseAgreementsAdditionalInformationDetails License Agreements - Additional Information (Details) Details 35 false false R36.htm 100360 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment, Net (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails Property and Equipment, Net - Schedule of Property and Equipment, Net (Details) Details 36 false false R37.htm 100370 - Disclosure - Property and Equipment, Net - Additional Information (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetails Property and Equipment, Net - Additional Information (Details) Details 37 false false R38.htm 100380 - Disclosure - Accrued Liabilities - Schedule of Accrued Liabilities (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails Accrued Liabilities - Schedule of Accrued Liabilities (Details) Details 38 false false R39.htm 100400 - Disclosure - Investments, Available-for-Sale - Schedule of Cost, Gross Unrealized Holding Gains, Gross Unrealized Holding Losses and Fair Value of Available for Sale Investments (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/DisclosureInvestmentsAvailableforsaleScheduleOfCostGrossUnrealizedHoldingGainsGrossUnrealizedHoldingLossesAndFairValueOfAvailableForSaleI Investments, Available-for-Sale - Schedule of Cost, Gross Unrealized Holding Gains, Gross Unrealized Holding Losses and Fair Value of Available for Sale Investments (Details) Details 39 false false R40.htm 100410 - Disclosure - Fair Value Measurements - Schedule of Assets Measured at Fair Value on Recurring Basis (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurements - Schedule of Assets Measured at Fair Value on Recurring Basis (Details) Details 40 false false R41.htm 100420 - Disclosure - Fair Value Measurements - Additional Information (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails Fair Value Measurements - Additional Information (Details) Details 41 false false R42.htm 100430 - Disclosure - Convertible Preferred Stock - Schedule of Convertible Preferred Stock Authorized and Issued and its Principal Terms (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStockScheduleOfConvertiblePreferredStockAuthorizedAndIssuedAndItsPrincipalTermsDetails Convertible Preferred Stock - Schedule of Convertible Preferred Stock Authorized and Issued and its Principal Terms (Details) Details 42 false false R43.htm 100440 - Disclosure - Convertible Preferred Stock - Additional Information (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails Convertible Preferred Stock - Additional Information (Details) Details 43 false false R44.htm 100450 - Disclosure - Equity Incentive Plans and Stock-Based Compensation - Additional Information (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureEquityIncentivePlansAndStockBasedCompensationAdditionalInformationDetails Equity Incentive Plans and Stock-Based Compensation - Additional Information (Details) Details 44 false false R45.htm 100460 - Disclosure - Equity Incentive Plans and Stock-Based Compensation - Summary of Option Activity (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureEquityIncentivePlansAndStockBasedCompensationSummaryOfOptionActivityDetails Equity Incentive Plans and Stock-Based Compensation - Summary of Option Activity (Details) Details 45 false false R46.htm 100470 - Disclosure - Equity Incentive Plans and Stock-Based Compensation - Summary of Fair Value of Stock Options Estimated Using Black-Scholes Merton Option Pricing Model Assumptions (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureEquityIncentivePlansAndStockBasedCompensationSummaryOfFairValueOfStockOptionsEstimatedUsingBlackScholesMertonOptionPricingModelAssumptionsDetails Equity Incentive Plans and Stock-Based Compensation - Summary of Fair Value of Stock Options Estimated Using Black-Scholes Merton Option Pricing Model Assumptions (Details) Details 46 false false R47.htm 100480 - Disclosure - Equity Incentive Plans and Stock-Based Compensation - Summary of Total Stock-based Compensation Expense (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureEquityIncentivePlansAndStockBasedCompensationSummaryOfTotalStockBasedCompensationExpenseDetails Equity Incentive Plans and Stock-Based Compensation - Summary of Total Stock-based Compensation Expense (Details) Details 47 false false R48.htm 100490 - Disclosure - Income Tax - Schedule of Provision for Income Taxes and Income Taxes Computed (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxScheduleOfProvisionForIncomeTaxesAndIncomeTaxesComputedDetails Income Tax - Schedule of Provision for Income Taxes and Income Taxes Computed (Details) Details 48 false false R49.htm 100500 - Disclosure - Income Tax - Significant Components of Deferred Tax Assets and Liabilities (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails Income Tax - Significant Components of Deferred Tax Assets and Liabilities (Details) Details 49 false false R50.htm 100510 - Disclosure - Income Tax - Additional Information (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxAdditionalInformationDetails Income Tax - Additional Information (Details) Details 50 false false R51.htm 100520 - Disclosure - Commitment and Contingencies - Additional Information (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureCommitmentAndContingenciesAdditionalInformationDetails Commitment and Contingencies - Additional Information (Details) Details 51 false false R52.htm 100530 - Disclosure - Commitment and Contingencies - Summary of Future Lease Payments of Operating Leases Liabilities (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureLeasePaymentsOfOperatingLeasesLiabilitiesDetails Commitment and Contingencies - Summary of Future Lease Payments of Operating Leases Liabilities (Details) Details 52 false false R53.htm 100540 - Disclosure - Commitment and Contingencies - Summary of Future Minimum Lease Payments Under Non-cancelable Operating Leases (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/DisclosureCommitmentAndContingenciesSummaryOfFutureMinimumLeasePaymentsUnderNoncancelableOperatingLeasesDetails Commitment and Contingencies - Summary of Future Minimum Lease Payments Under Non-cancelable Operating Leases (Details) Details 53 false false R54.htm 100550 - Disclosure - Employee Benefit Plan - Additional Information (Details) Sheet http://www.oricpharma.com/20211231/taxonomy/role/Role_DisclosureEmployeeBenefitPlanAdditionalInformationDetails Employee Benefit Plan - Additional Information (Details) Details 54 false false All Reports Book All Reports oric-20211231.htm oric-20211231.xsd oric-20211231_cal.xml oric-20211231_def.xml oric-20211231_lab.xml oric-20211231_pre.xml oric-ex10_10.htm oric-ex23_1.htm oric-ex31_1.htm oric-ex31_2.htm oric-ex32_1.htm oric-ex32_2.htm oric-ex4_3.htm img258523212_0.jpg img258523212_1.jpg img258523212_10.jpg img258523212_11.jpg img258523212_12.jpg img258523212_13.jpg img258523212_14.jpg img258523212_15.jpg img258523212_16.jpg img258523212_17.jpg img258523212_18.jpg img258523212_19.jpg img258523212_2.jpg img258523212_20.jpg img258523212_3.jpg img258523212_4.jpg img258523212_5.jpg img258523212_6.jpg img258523212_7.jpg img258523212_8.jpg img258523212_9.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true